AllerVie Health — Glenn Dale, Maryland

AllerVie Health is a clinical research site located in Glenn Dale, Maryland, United States 20769.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

AllerVie Health has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Clonal Mast Cell Disease, KIT D816V Mutation, Suspected KITD816V Mutated Clonal Mast Cell Disease.

Sponsors: Blueprint Medicines Corporation, Cogent Biosciences, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Glenn Dale

Browse all research sites in Maryland · View every site in Glenn Dale

• Callender Center for Clinical Research
• Callender Dermatology and Cosmetic Center
• Galderma Investigational Site 8012
• Allervie Clinical Research
• Research Site
• Investigative Site US046
• Foamix Investigational Site #388
• Eirion Research Site
• Investigational Site
• Call Suneva for Info
• Galderma Investigational Site (# 8012)

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AllerVie Health?

AllerVie Health has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AllerVie Health conducted?

AllerVie Health has 2 clinical trials on record, with 1 currently active. Their work covers Clonal Mast Cell Disease, KIT D816V Mutation, Suspected KITD816V Mutated Clonal Mast Cell Disease.

Is AllerVie Health accredited by Crixeo Clinical Trials?

AllerVie Health has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AllerVie Health?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.